Related Experiment Video
Updated: Jan 2, 2026
04:01
Point of Care Transcranial Color-Coded Duplex Ultrasound of the Middle Cerebral Artery
Published on: August 9, 2024
1.7K
A case of contrast-induced encephalopathy
Patrick Neilan1, Daniel Urbine2
1Department of Internal Medicine, UF Health Shands, Gainesville, Florida, USA.
BMJ Case Reports
|December 4, 2019
Summary
Contrast-induced encephalopathy is a rare neurological condition that can occur after receiving iodinated contrast agents. Prompt recognition and understanding of risk factors are crucial for managing this reversible condition in critical care settings.
Area of Science:
- Neurology
- Radiology
- Critical Care Medicine
Background:
- Encephalopathy presents a broad differential diagnosis for critical care physicians.
- Identifying the cause of encephalopathy is often challenging in acute settings.
Observation:
- An 81-year-old man developed acute neurological symptoms including headache, agitation, and altered mentation after a left heart catheterisation.
- Symptoms occurred immediately following administration of iopamidol, a low-osmolar iodinated contrast agent.
Findings:
- The patient experienced contrast-induced encephalopathy, a rare neurological disturbance.
- This condition is associated with intra-arterial, osmotic, iodinated contrast administration.
- The neurological disturbance was acute and reversible.
Implications:
- Recognizing contrast-induced encephalopathy is important for critical care physicians.
- Understanding risk factors and presentations can aid in timely diagnosis and management.
- This condition highlights the need for awareness of potential adverse reactions to contrast media.
Keywords:
adult intensive careheadache (including migraines)intensive careneurologyneurology (drugs And Medicines)
